A RECENT Australian study has
found that atrial fibrillation is
a significant predictor of early
mortality among people
(particularly women) aged 60
years or more.
According to the 20 year study,
published in Internal Medicine
Journal, women with atrial
fibrillation aged more than 60
years have a 127% greater risk
of dying compared with their
peers without atrial fibrillation.
For men the increased risk of
dying is 38%.
Interestingly researchers
found that the rates of atrial
fibrillation amongst men and
women are roughly the same
but that women are impacted
by AF to a much greater degree.
“We are unsure why atrial
fibrillation affects the life
expectancy of women more
than men but we do know that
other [AF risk factor] conditions
like diabetes have an impact
that is gender related,” said
study leader, Professor Leon
Simons of the University of
New South Wales.The above article was sent to subscribers in Pharmacy Daily's issue from 28 Jul 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Jul 11
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.